Wednesday, June 24, 2026

Elliptic Intelligence Used by the FBI in Action Against Huione, the $134 Billion Criminal Marketplace and Money Laundering Operation

 WASHINGTON - Wednesday, 24. June 2026 AETOSWire  


 


(BUSINESS WIRE)--Elliptic, the global leader in digital asset decisioning, today announced that its intelligence was used by the Federal Bureau of Investigation in today's action against the operators of Huione Group. The Justice Department announced the seizure of a cloud computing account used by subsidiaries of the Huione Group, a Cambodia-based corporate conglomerate.


First exposed by Elliptic in July 2024, Huione Guarantee was a Telegram-based marketplace serving online fraudsters across Southeast Asia. Merchants sold money laundering services, stolen personal data, websites and other goods and services necessary to perpetrate so-called “pig-butchering” scams and other online fraud., By the time Huione was forced offline, it had received more than $31 billion in cryptoasset transactions, making it the largest illicit online marketplace ever recorded, more than 25 times larger than Silk Road and AlphaBay combined.


Huione Group’s payments arm, Huione Pay, was also implicated in the laundering of proceeds of online scams. Huione Pay received at least $103 billion in cryptoasset payments over its lifetime and ran physical outlets across Cambodia.


This FBI action is the latest in a series of enforcement outcomes against online scam infrastructure and Chinese money laundering organizations built on Elliptic's intelligence, which also contributed to Telegram's shutdown of Huione Guarantee in May 2025, the US Treasury's FinCEN designation of Huione Group as a primary money laundering concern, and UK sanctions against Xinbi.


Simone Maini, CEO of Elliptic, said: "Huione was the largest illicit marketplace the world has ever seen. Elliptic’s data made the marketplace visible. Tracing the vast network behind it took years of intelligence work. This moment shows what the public and private sectors can achieve when they work together. These networks will keep adapting, and so will we."


About Elliptic


Elliptic is the leader in digital asset decisioning, we have built the most comprehensive platform for efficiently extracting cryptoasset data and intelligence across blockchains with the greatest accuracy.


Our platform’s unrivalled uptime, scalability, depth and breadth of our data and intelligence means exacting organizations choose Elliptic for their compliance, risk management, intelligence operations and blockchain infrastructure needs.


Founded in 2013, Elliptic is headquartered in London with offices in New York, Washington D.C., Miami, Dubai, Hong Kong, Singapore and Tokyo. To learn more, visit www.elliptic.co and follow us on LinkedIn and X.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260623117806/en/



Permalink

https://www.aetoswire.com/en/news/54559192


Contacts

 

Rachel Matthews

Global Marketing and Communications Director, Elliptic

rachel.matthews@elliptic.co

Quectel Introduces NXP-based FCM365X Wi-Fi 6, Bluetooth LE 5.4, Zigbee and Thread Module for Smart Home and Industrial IoT Solutions

 


BELGRADE, Serbia - 

(BUSINESS WIRE) -- Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the launch of the FCM365X, a dual band Wi-Fi 6 and Bluetooth Low Energy (BLE) 5.4 module that is based on the NXP® Semiconductors RW612 wireless MCU and supports multiple protocols, including Zigbee and Thread. The module is powered by a high-performance Arm® Cortex®-M33 processor with TrustZone® technology, operating at up to 260MHz. It integrates 1.2MB of SRAM and 8MB of Flash memory, with optional PSRAM expansion available, delivering the performance and memory capacity required for demanding IoT applications.


As smart home and industrial IoT ecosystems continue to evolve, support for interoperable standards such as Thread and Zigbee is becoming increasingly important. These protocols enable low-power, reliable mesh networking that allows devices to communicate across diverse ecosystems. Thread is gaining momentum as a key technology for Matter-enabled devices, while Zigbee continues to see widespread adoption in smart home and building automation applications. By integrating Wi-Fi, Bluetooth LE, Zigbee and Thread into a single module, the FCM365X provides developers with the flexibility to address multiple connectivity requirements while simplifying device design and supporting future-ready applications.


“A broad range of use cases across smart homes and industrial IoT are increasingly looking for compact, low power devices that offer secure, short-range connectivity,” commented Lazaros Kapsias, EMEA Product Manager, Quectel Wireless Solutions. “We see the FCM365X helping to meet these needs in the smart home ecosystem and in industrial scenarios. The wide range of supported interfaces, compliance with security standards and the compact form factor makes this module stand out.”


Ideal for power constrained use cases such as smart home and industrial IoT devices, the module features several low power consumption modes and keep-alive mechanisms to provide flexibility and versatility. The FCM365X also supports GPIO, SDIO, UART, USB and JTAG interfaces as standard with I2C, I2S, ADC, LCD and PWM interfaces supported in the QuecOpen solution. In addition, the module complies with WPA-PSK, WPA2-PSK and WPA3-SAE security standards, supporting the AES-128 encryption algorithm.


Supporting both the 2.4GHz and 5GHz Wi-Fi bands via a 1x1 antenna, the FCM365X features an RF coaxial connector and offers a PCB antenna as an option. Weighing just 1.51g and with dimensions of 25.5mm x 18.0mm x 3.16mm, the module is compact and ideal for optimizing the size and cost of end products while offering maximized design flexibility. Robustness is assured with the module operating in the -40 °C to +85 °C temperature range.


About Quectel


Quectel’s passion for a smarter world drives us to accelerate IoT innovation. A highly customer-centric organization, we are a global end-to-end IoT solutions provider backed by outstanding support and services.


With a worldwide team of over 5,800 professionals, we lead the way in delivering end-to-end IoT solutions, spanning cellular, GNSS, satellite, Wi-Fi and Bluetooth modules, high-performance antennas, value-added services and full turnkey offerings including ODM services and system integration.


With regional offices and support across the globe, our international leadership is devoted to advancing IoT and helping build a smarter world.


For more information, please visit: www.quectel.com or LinkedIn


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260624781458/en/



Permalink

https://www.aetoswire.com/en/news/2406202655857


Contacts

Media contact: media@quectel.com

MSCI Announces the Results of the MSCI 2026 Market Classification Review

 NEW YORK - 

(BUSINESS WIRE)--MSCI released the results of the MSCI 2026 Market Classification Review.


Key takeaways from this year's review include:


Reclassification of Bulgaria from Standalone to Frontier Market status

Assessment of shareholder transparency and coordinated trading concerns in the Indonesian and Turkish equity markets, acknowledging the announced steps undertaken by both markets to address these matters and noting the continued potential for future consultations on the appropriate treatment of these markets if credible progress is not observed

Acknowledgement of the removal of floor prices in Bangladesh, with a caution that any reintroduction could prompt a consultation on reclassification from Frontier to Standalone Market status

Ongoing monitoring of the implementation of measures aimed at improving the accessibility of the Korean equity market for international institutional investors

Reminder on the reclassification of Greece from Emerging to Developed Market status at the May 2027 Index Review

“The MSCI Market Classification Framework determines whether a market is developed, emerging, or frontier based on the accessibility and investability that international institutional investors actually experience,” said Raman Aylur Subramanian, Head of Market Classification and Taxonomies. “Index inclusion and market classification are not static judgments. They must be continuously assessed against market changes and the experience of international institutional investors. When market access or experiences worsen, our framework requires us to respond decisively. And when market accessibility and investability improve in a meaningful and sustained way, markets can progress through the classification framework, as seen with Bulgaria and Greece.”


More information related to the MSCI 2026 Market Classification Review, including the results of the 2026 MSCI Global Market Accessibility Review, can be viewed at: www.msci.com/market-classification.


Results of the Consultation on the Classification of Bulgaria


MSCI announced its decision to reclassify Bulgaria from Standalone Market status to Frontier Market status. The reclassification proposal was originally launched for consultation in 2024, after enough Bulgarian securities met the Size and Liquidity Requirements for Frontier Markets. The decision was subsequently deferred following feedback from international institutional investors, who cited limited market liquidity and the timing of the euro adoption.


Since then, conditions have materially improved. Market participants agreed that liquidity on the Bulgarian Stock Exchange (BSE) has improved meaningfully, supported by a higher number of securities meeting the Frontier Market Size and Liquidity Requirements and rising turnover. No significant operational challenges were identified following Bulgaria's transition to the euro, which was completed on January 1, 2026, when BSE's trading and post-trading infrastructure transitioned fully to euro denomination. Bulgaria had previously migrated to the European Central Bank's TARGET2-Securities (T2S) platform in September 2023, and following euro adoption, all settlements now occur in euros.


The reclassification will be implemented in one step across all standard, custom and derived MSCI Indexes, coinciding with the May 2027 Index Review. MSCI will share additional details on the implementation process in due course.


The accessibility report for Bulgaria is now reflected in the MSCI 2026 Global Market Accessibility Review report available at https://www.msci.com/market-classification.


Shareholder Transparency and Coordinated Trading Concerns


International institutional investors frequently raise concerns with MSCI when they experience persistent opacity in shareholding structures and suspect coordinated trading behavior. Both concerns materially limit investors' ability to assess true free float and to rely on observed market prices for portfolio construction and index replication, and they relate directly to the Information Flow and Market Infrastructure pillars of the MSCI Market Accessibility framework.


For Indonesia, market participants raised profound investability concerns stemming from these issues. MSCI acknowledges the recent transparency reforms announced by Otoritas Jasa Keuangan (OJK), PT Bursa Efek Indonesia (IDX), and PT Kustodian Sentral Efek Indonesia (KSEI), including enhanced disclosure of shareholders with ownership above 1%, more granular investor classification, the introduction of a High Shareholding Concentration (HSC) framework, and a roadmap to raise the minimum free float requirement to 15%. While these announcements represent a step in the right direction, what matters for international institutional investors is the consistent implementation and sustained effect of these measures across the market. MSCI will continue to assess their scope, consistency and sustained effectiveness in the context of free float determination and broader investability assessments. Should sufficient progress not be evident by the time of the November 2026 MSCI Index Review, MSCI will consider a range of options for the appropriate treatment for the Indonesia market, potentially including a consultation on the reclassification of Indonesia from Emerging Markets to Frontier Markets.


For Turkey, international institutional investors have highlighted recurring instances of possible coordinated trading behavior involving fund holdings closely affiliated with certain smaller, listed companies, with the effect of artificially inflating free float estimates. MSCI acknowledges the decision issued by the Capital Markets Board of Turkey (SPK), which recently introduced a framework for excluding fund-held stakes from the exchange’s free float calculations where the underlying beneficial ownership belongs to parties already excluded from free float. Nevertheless, market participants want to see the impact of these adjusted calculations in practice. Additionally, international investors have communicated that they seek further progress, including granular and timely disclosure of beneficial ownership, robust surveillance and enforcement against coordinated trading behavior, and a transparent, rules-based framework for the identification and treatment of securities exhibiting structurally distorted free float. If sufficient tangible and credible progress is not evident in the Turkey market by the time of the November 2026 MSCI Index Review, MSCI may launch a consultation on the appropriate treatment for Turkey and its eligible securities.


MSCI continues to welcome feedback on shareholder transparency and trading behavior in these markets.


Removal of Floor Prices in Bangladesh


Floor prices have now been removed from all affected securities in the Bangladesh equity market. MSCI welcomes this development. Floor prices severely hinder a market's accessibility, distorting price discovery and impairing the ability of international institutional investors to enter and exit positions at fair value, and their removal is an important step toward restoring the investability of the market.


MSCI cautions that the reintroduction of floor prices on any listed securities would once again severely impair the accessibility of the Bangladesh equity market. Should floor prices be reimposed, MSCI may launch a consultation on a potential reclassification of Bangladesh from Frontier Market status to Standalone Market status. MSCI continues to welcome feedback on the accessibility of the Bangladesh equity market.


Market Accessibility of Korea


From 2008 to 2014, MSCI consulted with global market participants on the potential reclassification of Korea from Emerging Market status to Developed Market status. Market participants identified the limited convertibility of the Korean won in the offshore currency market as a key barrier to reclassification. Other accessibility issues highlighted at the time included the rigidity of the investor ID system, the restrictions on in-kind transfers and off-exchange transactions, and the limited availability of investment instruments stemming from restrictions on the use of exchange data for the creation of financial products.


MSCI acknowledges the measures announced by Korean market authorities to address these long-standing concerns. However, investors have communicated that the underlying issues have not been fully resolved. The Korean won is not deliverable offshore. Even more concerning, onshore liquidity during the extended FX trading hours remains largely insufficient to support tight execution at standards comparable to those observed in developed markets, constraining FX operational flexibility for index replicators and others. International institutional investors will need to be convinced that this trading of the won in overnight markets in Korea will eventually provide large, deep and consistent pools of liquidity and tight bid/ask spreads that are comparable to day trading hours for other developed market currencies in the world. Operational adoption of omnibus accounts and in-kind transfers remains limited. Following the lifting of the short-selling ban, market participants continue to face significant operational burdens under the reinstated compliance regime. In addition, early pre-settlement funding requirements remain a burden for market participants.


MSCI will continue to monitor implementation and engage with market participants and Korean authorities. As a reminder, potential reclassification consultations require that all issues have been addressed, reforms have been fully implemented, and market participants have had ample time to thoroughly evaluate the sustained effectiveness of the changes.


Market Classification of Greece


On March 31, 2026, MSCI announced its decision to reclassify Greece from Emerging Market status to Developed Market status, following a consultation launched on January 26, 2026. The majority of consultation participants favored the proposed reclassification, recognizing that Greece's market infrastructure has converged with Developed European standards and meets the criteria for MSCI Developed Markets.


The reclassification will be implemented in one step across all standard, custom and derived MSCI Indexes, coinciding with the May 2027 Index Review. Once reclassified, Greece will be incorporated into the Developed Europe single market index construction process, and existing constituent rules will be applied to minimize turnover at the time of the reclassification.


-Ends-


About MSCI


MSCI (NYSE: MSCI Inc.) strengthens global markets by connecting participants across the financial ecosystem with a common language. Our research-based data, analytics and indexes, supported by advanced technology, set standards for global investors and help our clients understand risks and opportunities so they can make better decisions and unlock innovation. We serve asset managers and owners, private-market sponsors and investors, hedge funds, wealth managers, banks, insurers and corporates. To learn more, please visit www.msci.com.


The process for submitting a formal index complaint can be found on the index regulation page of MSCI’s website at: https://www.msci.com/index-regulation.


 

The data, data feeds, databases, reports, text, graphs, charts, images, videos, recordings, models, metrics, analytics, indexes, ratings, scores, cases, estimates, assessments, software, websites, products, services and other information and materials contained herein or delivered in connection with this notice (collectively, the “Information”) are copyrighted, trade secrets (when not publicly available), trademarks and proprietary property of MSCI Inc. or its subsidiaries (collectively, “MSCI”), MSCI’s licensors, direct or indirect suppliers and authorized sources, and/or any third party contributing to the Information (collectively, with MSCI, the “Information Providers”). All rights in the Information are reserved by MSCI and its Information Providers and user(s) shall not, nor assist others to, challenge or assert any rights in the Information. 


 

Unless you contact MSCI and receive its prior written permission, you must NOT use the Information, directly or indirectly, in whole or in part (i) for commercial purposes, (ii) in a manner that competes with MSCI or impacts its ability to commercialize the Information or its services, (iii) to provide a service to a third party, (iv) to permit a third party to directly or indirectly access, use or resell the Information, (v) to redistribute or resell the Information in any form, (vi) to include the Information in any materials for public dissemination such as fund factsheets, market presentations, prospectuses, and investor information documents (e.g. KIIDs or KIDs), (vii) to create or as a component of any financial products, whether listed or traded over the counter or on a private placement basis or otherwise, (viii) to create any indexes, ratings or other data products, including in derivative works combined with other indexes or data or as a policy, product or performance benchmarks for active, passive or other financial products, (ix) to populate a database, or (x) to train, use as an input to, or otherwise in connection with any artificial intelligence, machine learning, large language models or similar technologies except as licensed and expressly authorized under MSCI’s AI Contracting Supplement at https://www.msci.com/legal/supplemental-terms-for-client-use-of-artificial-intelligence.


 

The intellectual property rights of MSCI and its Information Providers may not be misappropriated or used in a competitive manner through the use of third-party data or financial products linked to the Information, including by using an MSCI index-linked future or option in a competing third-party index to provide an exposure to the underlying MSCI index or by using an MSCI index-linked ETF to create a financial product that provides an exposure to the underlying MSCI index without obtaining a license from MSCI.


 

The user or recipient of the Information assumes the entire risk of any use it may make, permit or cause to be made of the Information. NONE OF THE INFORMATION PROVIDERS MAKES ANY EXPRESS OR IMPLIED WARRANTIES OR REPRESENTATIONS WITH RESPECT TO THE INFORMATION (OR THE RESULTS TO BE OBTAINED BY THE USE THEREOF), AND TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, EACH INFORMATION PROVIDER EXPRESSLY DISCLAIMS ALL IMPLIED WARRANTIES (INCLUDING ANY IMPLIED WARRANTIES OF ORIGINALITY, ACCURACY, TIMELINESS, SUITABILITY, NON-INFRINGEMENT, COMPLETENESS, MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE) WITH RESPECT TO ANY OF THE INFORMATION. Without limiting any of the foregoing and to the maximum extent permitted by applicable law, in no event shall MSCI or any other Information Provider have any liability arising out of or relating to any of the Information, including for any direct, indirect, special, punitive, consequential (including lost profits) or any other damages, even if notified of the possibility of such damages. The foregoing shall not exclude or limit any liability that may not by applicable law be excluded or limited.


 

The Information, including index construction, ratings, historical data, or analysis, is not a prediction or guarantee of future performance, and must not be relied upon as such. Past performance is not indicative of future results. The Information may contain back tested data. Back-tested performance based on back-tested data is not actual performance but is hypothetical. There are frequently material differences between back tested performance results and actual results subsequently achieved by any investment strategy. The Information may include “Signals,” defined as quantitative attributes or the product of methods or formulas that describe or are derived from calculations using historical data. Signals are inherently backward-looking because of their use of historical data, and they are inherently inaccurate, not intended to predict the future and must not be relied upon as such. The relevance, correlations and accuracy of Signals frequently change materially over time. 


 

The Information may include data relating to indicative prices, evaluated pricing or other information based on estimates or evaluations (collectively, “Evaluations”) that are not current and do not reflect real-time traded prices. No evaluation method, including those used by the Information Providers, may consistently generate evaluations or estimates that correspond to actual “traded” prices of any relevant securities or other assets. Evaluations are subject to change at any time without notice and without any duty to update or inform you, may not reflect prices at which actual transactions or collateral calls may occur or have occurred. The market price of securities, financial instruments, and other assets can be determined only if and when executed in the market. There may be no, or may not have been any, secondary trading market for the relevant securities, financial instruments or other assets. Private capital, equity, credit and other assets and their prices may be assessed infrequently, may not be priced on a secondary market, and shall not be relied upon as an explicit or implicit valuation of a particular instrument. Any reliance on fair value estimates and non-market inputs introduces potential biases and subjectivity. Internal Rate of Return metrics are not fully representative without full disclosure of fund cash flows, assumptions, and time horizons.


 

The Information does not constitute, and must not be relied upon as, investment advice, credit ratings, or proxy advisory or voting services. None of the Information Providers, their products or services, are fiduciaries or make any recommendation, endorsement, or approval of any investment decision or asset allocation. Likewise, the Information does not represent an offer to sell, a solicitation to buy, or an endorsement of any security, financial product, instrument, investment vehicle, or trading strategy, whether or not linked to or in any way based on any MSCI index, rating, subcomponent, or other Information (collectively, “Linked Investments”).The Information should not be relied on and is not a substitute for the skill, judgment and experience of any user when making investment and other business decisions. MSCI is not responsible for any user’s compliance with applicable laws and regulations. All Information is impersonal, not tailored to the needs of any person, entity or group of persons, not objectively verifiable in every respect, and may not be based on information that is important to any user.


 

It is not possible to invest in an index. Exposure to an asset class or trading strategy or other category represented by an index is only available through third party investable instruments (if any) based on that index. MSCI makes no assurance that any Linked Investments will accurately track index performance or provide positive investment returns. Index returns do not represent results of actual trading of investible assets/securities. MSCI maintains and calculates indexes but does not manage assets. The calculation of indexes and index returns may deviate from the stated methodology. Index returns do not reflect payment of any sales charges or fees an investor may pay to purchase securities underlying the index or Linked Investments. The imposition of these fees and charges would cause the performance of a Linked Investment to be different than the MSCI index performance.


 

Information provided by MSCI Solutions LLC and certain related entities (“MSCI Solutions”), including materials utilized in MSCI sustainability and climate products, have not been submitted to, nor received approval from any regulatory body. MSCI sustainability and climate offerings, research and data are produced by, and ratings are solely the opinion of MSCI Solutions. Other MSCI products and services may utilize information from MSCI Solutions, Barra LLC or other affiliates. More information can be found in the relevant methodologies on www.msci.com. MSCI Indexes are administered by MSCI Limited (UK) and MSCI Deutschland GmbH. No regulated use of any MSCI private real assets indexes in any jurisdiction is permitted without MSCI’s express written authorization. The process for applying for MSCI’s express written authorization can be found at: https://www.msci.com/index-regulation.


 

MSCI receives compensation in connection with licensing its indexes and other Information to third parties. MSCI Inc.’s revenue includes fees based on assets in Linked Investments. Information can be found in MSCI Inc.’s company filings on the Investor Relations section of msci.com. Issuers mentioned in MSCI Solutions materials or their affiliates may purchase research or other products or services from one or more MSCI affiliates, manage financial products such as mutual funds or ETFs rated by MSCI Solutions or its affiliates or are based on MSCI Indexes. Constituents of MSCI equity indexes are listed companies, which are included in or excluded from the indexes according to the application of the relevant index methodologies. Constituents in MSCI Inc. equity indexes may include MSCI Inc., clients of MSCI or suppliers to MSCI. MSCI Solutions has taken steps to mitigate potential conflicts of interest and safeguard the integrity and independence of its research and ratings.


 

MIFID2/MIFIR notice: MSCI Solutions does not distribute or act as an intermediary for financial instruments or structured deposits, nor does it deal on its own account, provide execution services for others or manage client accounts. No MSCI product or service supports, promotes or is intended to support or promote any such activity. MSCI Solutions is an independent provider of sustainability and climate data. All use of indicative prices for carbon credits must comply with any rules specified by MSCI. All transactions in carbon credits must be traded “over-the-counter” (i.e. not on a regulated market, trading venue or platform that performs a similar function to a trading venue) and result in physical delivery of the carbon credits.


 

You may not remove, alter, or obscure any attribution to MSCI or notices or disclaimers that apply to the Information. MSCI, Barra, RiskMetrics, and other MSCI brands and product names are the trademarks, service marks, or registered trademarks of MSCI or its subsidiaries in the United States and other jurisdictions. The Global Industry Classification Standard (GICS) was developed by and is the exclusive property of MSCI and S&P Dow Jones Indices. “Global Industry Classification Standard (GICS)” is a service mark of MSCI and S&P Dow Jones Indices. Terms such as including, includes, for example, such as and similar terms used herein are without limitation.


 

MSCI and its Information Providers may use automated technologies and artificial intelligence to help generate content and output incorporated in the Information.


 

Privacy notice: For information about how MSCI collects and uses personal data, please refer to our Privacy Notice at: https://www.msci.com/privacy-pledge. For copyright infringement claims contact us at dmca@msci.com. This notice is governed by the laws of the State of New York without regard to conflict of laws principles.


 


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260623223577/en/



Permalink

https://aetoswire.com/en/news/54559195


Contacts

 

Media Inquiries

PR@msci.com

Melanie Blanco +1 212 981 1049

Konstantinos Makrygiannis +44 77 6893 0056

Tina Tan +852 2844 9320


MSCI Global Client Service

EMEA Client Service + 44 20 7618 2222

Americas Client Service +1 888 588 4567

Asia Pacific Client Service + 852 2844 9333

New Pivotal Study Data Show Takeda’s Oveporexton Improved Daily Function, Cognition and Nighttime Sleep for People with Narcolepsy Type 1

 - Secondary and Exploratory Endpoint Results from Phase 3 Studies Presented at SLEEP 2026 Underscore Improvements with Oveporexton Across a Broad Range of Daytime and Nighttime Symptoms

- Takeda is on Track to Bring the First and Only Orexin Agonist to People Living with Narcolepsy Type 1 with Regulatory Submissions Under Review


 


(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today presented additional results from two pivotal studies at SLEEP 2026, showing oveporexton (TAK-861), an oral orexin receptor 2 (OX2R)-selective agonist, improved daily functioning as well as cognitive and sleep-related symptoms associated with narcolepsy type 1 (NT1).1,2,3 Oveporexton is designed to address the underlying orexin deficiency that causes NT1 by restoring orexin signaling. These data, along with previously disclosed Phase 3 results, demonstrated improvement across the broad disease spectrum, supporting the potential of oveporexton to redefine the standard of care for NT1.4


"Narcolepsy type 1 is a 24-hour disease driven by orexin deficiency, and while excessive daytime sleepiness and cataplexy are the most recognized symptoms, many people experience additional bothersome symptoms such as cognitive difficulties and disrupted nighttime sleep," said Emmanuel Mignot, M.D., Ph.D., principal investigator for the FirstLight (TAK-861-3001) Phase 3 study. "Oveporexton has demonstrated significant improvement across a broad range of NT1 symptoms, daily functioning and quality of life with the potential to shift disease management beyond incremental symptom relief.”


The presentations highlighted results from secondary and exploratory endpoints from two global, multicenter, placebo-controlled studies—FirstLight (TAK-861-3001; twice-daily 2mg, 1mg and placebo) and RadiantLight (TAK-861-3002; twice-daily 2mg and placebo)—including:


Functioning: At all doses, oveporexton significantly improved daily functioning at week 12 compared to placebo (p<0.001) across the six domains of the Functional Impacts of Narcolepsy Instrument (FINI). Most patients reached or exceeded the published normative domain thresholds, underscoring oveporexton’s ability to allow individuals to manage their everyday lives.5 FINI reflects the domains that are of highest impact for NT1 including tiredness, cognitive functioning, cataplexy, social activities, everyday activities and everyday responsibilities.

Cognition: Oveporexton improved cognitive symptoms associated with NT1 compared to placebo, as measured using objective neuropsychological tests of attention, executive function and memory along with patient-reported measures. On the FINI Cognitive Function domain, approximately 70% of patients across all doses reported no significant cognitive difficulties compared to approximately 15% of patients in the placebo arm.

Nighttime Sleep: Exploratory endpoints demonstrated that oveporexton improved quality of sleep across both studies. Across all doses, most patients reported no hallucinations or sleep paralysis and most patients on the 2/2mg dose reported meaningful reductions in disturbed nighttime sleep from baseline. Additionally, the timing and pattern of rapid eye movement (REM) sleep shifted toward those seen in healthy controls.

"Narcolepsy type 1 is not defined by a single symptom, which is why we designed a comprehensive Phase 3 program to evaluate the effect of oveporexton on the broad disease impact,” said Sarah Sheikh, M.Sc., B.M., B.Ch., MRCP, Head, Neuroscience Therapeutic Area Unit and Global Development at Takeda. “We are grateful to the patients, caregivers and healthcare providers who have been a part of this journey. With oveporexton under review by multiple regulatory agencies, we are on the cusp of bringing the first and only orexin agonist to the narcolepsy type 1 community, with the potential to redefine the standard of care if approved.”


Takeda will present additional data at the conference, including pooled analyses from previously presented Phase 3 results, data evaluating the impact of oveporexton in reducing microsleeps and an evaluation of the holistic symptom impact of NT1 in the United States.


About Oveporexton (TAK-861)


Oveporexton (TAK-861) is an investigational orexin receptor 2 (OX2R)-selective agonist, which selectively stimulates the OX2R to restore signaling and address the underlying orexin deficiency that causes narcolepsy type 1 (NT1). By activating OX2Rs, oveporexton is designed to promote wakefulness and reduce abnormal rapid eye movement (REM)-sleep like phenomena, including cataplexy, to address a broad spectrum of daytime and nighttime symptoms. The United States Food and Drug Administration (FDA) accepted the New Drug Application (NDA) and granted Priority Review for oveporexton, with a Prescription Drug User Fee Act (PDUFA) goal date in the third quarter of this calendar year. Regulatory submissions for oveporexton are also under review in China and Japan, with additional submissions planned throughout the year. Oveporexton is an investigational compound that has not been approved for use by any regulatory authority.


About the FirstLight and RadiantLight Phase 3 Orexin Studies


FirstLight (TAK-861-3001; NCT06470828) and RadiantLight (TAK-861-3002; NCT06505031) are global, multicenter, placebo-controlled studies to evaluate the efficacy, safety and tolerability of oveporexton compared to placebo in patients with narcolepsy type 1 (NT1) over 12 weeks. The studies were conducted in 19 countries, with enrollment completed within six months. The FirstLight study enrolled 168 participants randomized to one of three dosing arms (twice-daily 2mg, 1mg and placebo). The RadiantLight study enrolled 105 participants randomized to two dosing arms (twice-daily 2mg and placebo). More than 95 percent of the participants who completed the studies enrolled in the ongoing long-term extension (LTE) study.


About Takeda


Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit www.takeda.com.


Important Notice


For the purposes of this notice, “press release” means this document, any oral presentation, any question-and-answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release (including any oral briefing and any question-and-answer in connection with it) is not intended to, and does not constitute, represent or form part of any offer, invitation or solicitation of any offer to purchase, otherwise acquire, subscribe for, exchange, sell or otherwise dispose of, any securities or the solicitation of any vote or approval in any jurisdiction. No shares or other securities are being offered to the public by means of this press release. No offering of securities shall be made in the United States except pursuant to registration under the U.S. Securities Act of 1933, as amended, or an exemption therefrom. This press release is being given (together with any further information which may be provided to the recipient) on the condition that it is for use by the recipient for information purposes only (and not for the evaluation of any investment, acquisition, disposal or any other transaction). Any failure to comply with these restrictions may constitute a violation of applicable securities laws.


The companies in which Takeda directly and indirectly owns investments are separate entities. In this press release, “Takeda” is sometimes used for convenience where references are made to Takeda and its subsidiaries in general. Likewise, the words “we”, “us” and “our” are also used to refer to subsidiaries in general or to those who work for them. These expressions are also used where no useful purpose is served by identifying the particular company or companies.


Forward-Looking Statements


This press release and any materials distributed in connection with this press release may contain forward-looking statements, beliefs or opinions regarding Takeda’s future business, future position and results of operations, including estimates, forecasts, targets and plans for Takeda. Without limitation, forward-looking statements often include words such as “targets”, “plans”, “believes”, “hopes”, “continues”, “expects”, “aims”, “intends”, “ensures”, “will”, “may”, “should”, “would”, “could”, “anticipates”, “estimates”, “projects”, “forecasts”, “outlook” or similar expressions or the negative thereof. These forward-looking statements are based on assumptions about many important factors, including the following, which could cause actual results to differ materially from those expressed or implied by the forward-looking statements: the economic circumstances surrounding Takeda’s global business, including general economic conditions in Japan and the United States and with respect to international trade relations; competitive pressures and developments; changes to applicable laws and regulations, including tax, tariff and other trade-related rules; challenges inherent in new product development, including uncertainty of clinical success and decisions of regulatory authorities and the timing thereof; uncertainty of commercial success for new and existing products; manufacturing difficulties or delays; fluctuations in interest and currency exchange rates; claims or concerns regarding the safety or efficacy of marketed products or product candidates; the impact of health crises, like the novel coronavirus pandemic; the success of our environmental sustainability efforts, in enabling us to reduce our greenhouse gas emissions or meet our other environmental goals; the extent to which our efforts to increase efficiency, productivity or cost-savings, such as the integration of digital technologies, including artificial intelligence, in our business or other initiatives to restructure our operations will lead to the expected benefits; and other factors identified in Takeda’s most recent Annual Report on Form 20-F and Takeda’s other reports filed with the U.S. Securities and Exchange Commission, available on Takeda’s website at: https://www.takeda.com/investors/sec-filings-and-security-reports/ or at www.sec.gov. Takeda does not undertake to update any of the forward-looking statements contained in this press release or any other forward-looking statements it may make, except as required by law or stock exchange rule. Past performance is not an indicator of future results and the results or statements of Takeda in this press release may not be indicative of, and are not an estimate, forecast, guarantee or projection of Takeda’s future results.


Medical Information


This press release contains information about products that may not be available in all countries, or may be available under different trademarks, for different indications, in different dosages, or in different strengths. Nothing contained herein should be considered a solicitation, promotion or advertisement for any prescription drugs including the ones under development.


References


1 Plazzi G, Dauvilliers Y, Pizza F, et al. Effect of the Oral Orexin Receptor 2 Agonist Oveporexton (TAK-861) on Functional Impacts of Narcolepsy Type 1: Results from Two Phase 3 Studies. Presented at: SLEEP 2026; 14-17 June 2026; Baltimore, MD.

2 Pizza F, Dauvilliers Y, Del Rio Villegas R, et al. Oveporexton (TAK-861) Improves Cognitive Symptoms in Patients with Narcolepsy Type 1: Results from Two Randomized, Placebo-controlled Phase 3 Trials. Presented at: SLEEP 2026; 14-17 June 2026; Baltimore, MD.

3 Barateau L, Gong Y, Dauvilliers Y, et al. Effects of Treatment with Oveporexton, an Orexin Receptor 2 Agonist, on Sleep in People with Narcolepsy Type 1: Phase 3 Results. Presented at: SLEEP 2026; 14-17 June 2026; Baltimore, MD.

4 The topline results of these studies were shared on September 8, 2025, in “Takeda Presents Orexin Data from Landmark Oveporexton (TAK-861) Phase 3 Program in Narcolepsy Type 1 at World Sleep 2025.”

5 Crawford S, et al. Sleep 2024;47(suppl 1):A288.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260615651327/en/



Permalink

https://www.aetoswire.com/en/news/1606202655689


Contacts

Investor Relations


Christopher O’Reilly

takeda.ir.contact@takeda.com


Media Relations


Tsuyoshi Tada (Tokyo)

Toiawase_kouhou@takeda.co.jp


Kristi Bond (Boston)

Media_relations@takeda.com


 

Tuesday, June 23, 2026

Andersen Global Adds Andersen in Indonesia

 SAN FRANCISCO - Tuesday, 23. June 2026 AETOSWire 


(BUSINESS WIRE) -- Andersen Global strengthens its footprint in Southeast Asia as VDB Loi in Indonesia rebrands to Andersen in Indonesia, becoming the newest member firm to join the organization.


Andersen in Indonesia provides tax and legal advisory services to multinational companies and foreign investors operating in the Indonesian market. The firm combines decades of market experience with a practical approach focused on delivering clear, tailored guidance across complex regulatory and cross-border matters.


“Adopting the Andersen brand reflects our commitment to providing clients with high-quality, practical tax and legal advice supported by broader international collaboration,” said Tommy Hendharto Oetomo, managing partner of Andersen in Indonesia. “Clients operating in Indonesia require increasingly coordinated cross-border support. Becoming a member firm strengthens our ability to deliver that service with consistency and clarity.”


“Indonesia remains an important market for organizations investing and expanding throughout Southeast Asia,” said Mark L. Vorsatz, global chairman and CEO of Andersen. “The addition of Andersen in Indonesia further strengthens our presence in the region and builds on the strong collaboration already established with Andersen in Vietnam and Andersen in Cambodia.”


Andersen Global is an international association of legally separate, independent member firms comprised of tax, legal, and valuation professionals around the world. Established in 2013 by U.S. member firm Andersen Tax LLC, Andersen Global now has more than 50,000 professionals worldwide and a presence in over 1,000 locations through its member firms and collaborating firms.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260623146384/en/



Permalink

https://www.aetoswire.com/en/news/2306202655836


Contacts

Megan Tsuei

Andersen Global

415-764-2700


 

Lenovo Recognized in the Gartner® Supply Chain Top 25 for 2026

 (BUSINESS WIRE)--Lenovo has once again been ranked in the Gartner® Supply Chain Top 25 for 2026, achieving its highest-ever ranking at seventh globally. The Gartner Supply Chain Top 25 is a renowned annual ranking of the world’s superior supply chains. Now in its 22nd year, the Gartner Supply Chain Top 25 identifies, celebrates and profiles excellence in supply chain management. Supply chain teams use the Gartner Supply Chain Top 25 to benchmark performance, transform operations and lead in the future. Lenovo ranked eighth in 2025, 10th in 2024, and eighth in 2023.


AI Builds Greater Supply Chain Resilience


Global supply chains have faced unprecedented disruption over the past 12 months, driven by tariffs, component shortages, and geopolitical tensions. Lenovo’s strength amid these challenging circumstances has been its ability to build on its AI infrastructure behind its global supply chain, improving resilience, adaptability and execution at speed and scale.


Over the past year, Lenovo has evolved its Supply Chain Intelligence “digital nervous system” to develop iChain, a continuously learning orchestration system that coordinates thousands of suppliers and more than 30 manufacturing sites globally. iChain is delivering tangible results for Lenovo’s supply chain operations, including 60% faster decision-making, near real-time disruption response, and a 90% automation of network simulations that reduces manual analysis from two to three weeks down to two to three hours.


Lenovo remains committed to sustainability and continues to focus on future-proofing its operations by making the supply chain more resilient and intelligent.


“At Lenovo, we’ve always considered our Global Supply Chain as a key pillar of our operational excellence,” said Che Min Tu, Senior Vice President and Group Operations Officer, Lenovo. “Over the past 12 months, the ability to respond quickly to disruption has become essential for every business. By fully integrating AI into our operations, we’ve been able to meet our customer needs more quickly and respond to complex situations. We not only withstand disruption; we become stronger because of it. It’s this approach that’s helped Lenovo navigate changing market conditions, maintain a competitive advantage, and deliver its strongest year in the company’s history.”


Resilience Delivers Measurable Business Results


This resilience is translating into business performance. Lenovo retained its number one position in global PC market share, with the gap to the second-ranked competitor widening to its largest level in 15 years.


At the same time, integrating the Infrastructure Solutions Group supply chain into the broader global network has helped accelerate growth in Lenovo’s infrastructure business, supporting record operating profit and margins.


As global supply chains continue to grow more complex, Lenovo’s model is evolving beyond the high-volume PC business, where a single device can include an average of 2,500 components, to meet hypergrowth demand for AI infrastructure, enterprise solutions, and next-generation workloads. This positions Lenovo to maintain leadership in the global supply chain landscape by scaling AI server manufacturing, expanding liquid-cooled server capacity, and strengthening its global-local manufacturing network.


Lenovo’s Global, Anti-Fragile Supply Chain Strategy


Today, Lenovo’s supply chain spans more than 30 manufacturing sites in 10 markets across Asia Pacific, China, Europe, the Middle East and Africa, North America, and South America. Last year, Lenovo broke ground on a new manufacturing base in Riyadh, Kingdom of Saudi Arabia. Once operational, the advanced manufacturing facility will manufacture PCs, smartphones, and servers for the Middle East and Africa market, and will include a research and development center, talent enablement programs, and a customer experience center. Lenovo is committed to supporting the creation of thousands of local jobs, enabling knowledge transfer, and driving long-term economic value creation in Saudi Arabia.


In addition, Lenovo’s manufacturing site in Monterrey, Mexico, was recently recognized as one of 12 new additions to the World Economic Forum’s Global Lighthouse Network, a community of 201 leading manufacturers recognized for applying advanced technologies at scale. It is the second Lenovo site to receive this recognition, following the company’s site in Hefei, China, which was recognized in January 2023.


In September 2025, Lenovo announced a major investment and job expansion at its U.S. manufacturing and fulfilment campus in Whitsett, North Carolina. The three‑building campus spans more than 800,000 square feet and employs approximately 1,100 people. The site supports server manufacturing, rack integration, and order fulfilment for customers across the United States.


How are companies ranked in the Gartner Supply Chain Top 25?


A Top 25 supply chain ranking is based on an equal weighting of business metrics and community opinion.


Business metrics comprise financial and environmental, social and governance (ESG) metrics. Financial metrics are based on a combination of three-year weighted return on physical assets (ROPA), ROPA change and revenue growth, plus inventory turns across the year. ESG data is derived from trusted third-party sources in the areas of commitment, transparency and performance across each area of ESG.


Community opinion is based on the feedback of peer voters from the community and Gartner experts. Peer voters cast votes for their personal choice of the Top 25 supply chains. They base their decisions on perceived end-to-end supply chain maturity and leadership, specifically the supply chains that are run as strategic assets to deliver business and societal outcomes by partnering beyond their own organizations and that are thriving through uncertainty.


Read the full Gartner Supply Chain Top 25 for 2026 Report here.


Gartner Press Release: Gartner Announces 2026 Rankings of the Global Supply Chain Top 25


GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved. Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. GARTNER is a registered trademark and service mark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission. All rights reserved.


About Lenovo


Lenovo is a US$83 billion revenue global technology powerhouse, ranked #196 in the Fortune Global 500, and serving millions of customers every day in 180 markets. Guided by its vision of “Smarter Technology for All”, Lenovo is executing a Hybrid AI strategy that spans Personal AI – one personal AI, multiple devices; and Enterprise AI – helping customers turn data into insights and value. This strategy is delivered through the Group’s commitment to world-class innovation and a full-stack AI portfolio, including devices (PCs, workstations, smartphones, tablets, accessories), infrastructure solutions (server, storage, edge, high performance computing and software defined infrastructure), as well as software, solutions, and services. With a global footprint spanning more than 20 research and development locations and a global supply chain that includes more than 30 manufacturing sites across 10 markets, Lenovo is widely recognized for its operational excellence. Lenovo is listed on the Hong Kong stock exchange under Lenovo Group Limited (HKSE: 992) (ADR: LNVGY). Learn more at www.lenovo.com and follow the latest news in our newsroom.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260622313869/en/



Permalink

https://aetoswire.com/en/news/54557844


Contacts

 

Stuart Gill

E: sgill@lenovo.com

Mary Kay Extends Winning Streak With Fourth Year as #1 in Global Direct Selling Beauty

DALLAS - Tuesday, 23. June 2026


Euromonitor International Recognizes Mary Kay’s Sustained Leadership In Skin Care And Color Cosmetics


(BUSINESS WIRE) -- Mary Kay Inc., the iconic beauty and entrepreneurship company, has once again been named the #1 Direct Selling Brand of Skin Care and Color Cosmetics in the World1 by Euromonitor International, sustaining its legacy of excellence for the fourth consecutive year.


“Earning the #1 global ranking from Euromonitor for the fourth consecutive year comes as a powerful endorsement of the impact of our Independent Beauty Consultants around the world who drive our success every day,” said Ryan Rogers, Chief Executive Officer of Mary Kay Inc. “Their entrepreneurial spirit, combined with our transformational investments in R&D and cutting-edge technology enable us to deliver high-performance skin and beauty solutions. This is the winning ticket that makes us one of the world’s most beloved consumer brands.”


Euromonitor International is the foremost provider of global business intelligence, market analysis, and consumer insights with over 50 years of conducting market research across more than 100 countries.


"Euromonitor International’s rankings represent the highest standard of global market performance, backed by rigorous, independent data and analysis,” stated Anthony Irwin, senior vice president of research at Euromonitor International. “Mary Kay’s continued leadership in direct selling beauty highlights its ability to deliver consistent value, quality, and relevance in a highly competitive global marketplace.”


Topping the charts:


In addition to the Euromonitor recognition, Mary Kay consistently earns global accolades among top global beauty companies.


In 2025 alone, Mary Kay garnered 41 beauty and industry awards around the world including being named #9 on the Forbes 2025 Best Brands for Social Impact2 list out of 3,900 brands.


In 2026, Mary Kay ranked #20 in the Women’s Wear Daily Beauty Inc.’s 2025 Top 100 Beauty Companies.


Forbes ranked Mary Kay #2 on its 2026 Best Customer Service3 list.


Global Innovation Powerhouse


Mary Kay continues to deliver high-performance skincare and color cosmetics through a combination of scientific innovation, consumer insights, and personalized service.


Mary Kay has been issued over 1,600 patents worldwide in products, technologies, and packaging.


Mary Kay’s Richard R. Rogers global Manufacturing and R&D Center in Texas can produce up to 1 million products per day.


64% of Mary Kay’s R&D scientists and 79% of Global Brand and Global Creative teams are women4.


Mary Kay’s portfolio includes award-winning and fan-favorite products such as:


TimeWise® skincare line


Clinical Solutions® advanced skincare


TimeWise® 3D Foundations (Matte and Luminous)


Oil-Free Eye Makeup Remover


Ultimate Mascara™


Unlimited® Lip Gloss


Mary Kay products are sold by best-in-class Independent Beauty Consultants in 40 markets worldwide who provide personalized service to customers in person and online at www.MaryKay.com (USA), and on social and digital media channels.


Did You Know?

Economic Impact of Direct Selling by the Numbers:


Globally:


The global direct selling market is projected to reach approximately USD 815.4 billion by 2034, rising from an estimated USD 418.4 billion in 2024.5


In the U.S.:


73% of direct sellers in the U.S. are women.6


$34.7 billion in retail sales generated through direct selling activities.7


About Mary Kay


One of the original glass ceiling breakers, Mary Kay Ash founded her dream beauty brand in Texas in 1963 with one goal: to enrich women’s lives. That dream has blossomed into a global company with millions of independent sales force members in 40 markets. For over 60 years, the Mary Kay opportunity has empowered women to define their own futures through education, mentorship, advocacy, and innovation. Mary Kay is dedicated to investing in the science behind beauty and manufacturing cutting-edge skincare, color cosmetics, nutritional supplements, and fragrances. Mary Kay believes in preserving our planet for future generations, protecting women impacted by cancer and domestic abuse, and encouraging youth to follow their dreams. Learn more at marykayglobal.com. Find us on Facebook, Instagram, and LinkedIn, or follow us on X.


About Euromonitor International


Euromonitor International leads the world in global market intelligence into industries, companies, economies and consumers. With over 50 years at the cutting edge of the industry, we blend deep human expertise with AI technology and analytics, to deliver insights that drive confident, high-stakes decisions—at speed and scale. Our global network and proprietary data empower you to unlock growth opportunities and navigate change. We have specialist teams in 16 offices around the world and a network of on-the-ground analysts in over 100 countries, providing cultural and business nuances others miss. We research 210 countries and jurisdictions and 99.9% of the world’s consumers, helping our clients to make sense of global markets.


1 “Source Euromonitor International Limited; Beauty and Personal Care 2026 Edition, value sales at RSP, 2025 Data”

2 Haniya Rae, Contributor. (April 17, 2025). “Meet America’s Best Brands For Social Impact 2025.” https://www.forbes.com/sites/haniyarae/2025/04/17/meet-americas-best-brands-for-social-impact-2025/.

3 Alan Schwarz, (October 14, 2025). “2026 Best Customer Service.” https://www.forbes.com/lists/best-customer-service/.

4 Women and Leadership Representation at Mary Kay, May 2026.

5 Tajammul Pangarkar. (March 24, 2025). Direct Selling Market to Reach USD 815.4 Billion by 2034 at 6.9% CAGR. www.news.market.us/direct-selling-market-news

6 World Federation of Direct Selling Associations. (November 2025). 2024 Global Annual Direct Selling Statistical Data Report. https://wfdsa.org/wp-content/uploads/2025/12/WFDSA-STATS-Report-2024-2025-V1.pdf

7 DSEF 2025 US Growth & Outlook Study. DSEF 2026 US Economic Impact Report.


 


View source version on businesswire.com: https://www.businesswire.com/news/home/20260623487381/en/



Permalink

https://www.aetoswire.com/en/news/2306202655835


Contacts

Mary Kay Inc. Corporate Communications

newsroom.marykay.com

972.687.5332 or media@mkcorp.com